Publications
Chosen filters:
Chosen filters:
Effectiveness of digital health interventions for diabetes: systematic review of systematic reviews Institute of Tropical Medicine
Background
The use of digital health technologies to tackle diabetes has been particularly flourishing in recent years. Previous studies have shown to varying degrees that these technologies can have an impact on diabetes prevention and management.
Objective
The aim of this review is to summarize the best evidence regarding the effectiveness of digital health interventions to improve one or more diabetes indicators.
...
The use of digital health technologies to tackle diabetes has been particularly flourishing in recent years. Previous studies have shown to varying degrees that these technologies can have an impact on diabetes prevention and management.
Objective
The aim of this review is to summarize the best evidence regarding the effectiveness of digital health interventions to improve one or more diabetes indicators.
...
Chances as Legally Protected Assets Hasselt University KU Leuven
The doctrine of loss of a chance has been deployed by courts jurisdictions in cases presenting causal uncertainty for over a century. In both the civil and common law jurisdictions where it is applied, however, there is debate as to the precise rationale and scope of application of the doctrine. In this working paper we compare theories, cases and practices from four Western European jurisdictions: France, Belgium, the Netherlands and England ...
Use of Biosimilars in Pediatric Inflammatory Bowel Disease: An Updated Position Statement of the Pediatric IBD Porto Group of ESPGHAN KU Leuven
Biologic therapies have changed the outcome of both adult and pediatric patients with Inflammatory Bowel Disease (IBD). In September 2013, the first biosimilar of infliximab was introduced into the pharmaceutical market. In 2015, a first position paper on the use of biosimilars in pediatric IBD was published by the ESPGHAN IBD Porto group. Since then, more data have accumulated for both adults and children demonstrating biosimilars are an ...
Optimising Biological Treatment for Patients with Immune-Mediated Inflammatory Diseases Exposure-Response Relation and Therapy-Related Effects KU Leuven
The introduction of biologics has heralded a new era for treatment of immune-mediated inflammatory diseases (IMIDs), including ankylosing spondylitis (AS), psoriasis and inflammatory bowel diseases (IBD). Although these agents show efficacy in many patients, a substantial proportion of patients fails to respond, loses response over time or develops potentially therapy-limiting adverse events. One possible mechanism explaining the failure of ...
Parenting adolescents with Autism Spectrum Disorder KU Leuven
Parents of children and adolescents with autism spectrum disorder (ASD) face specific challenges in parenting. However, little is known about parenting behaviours among parents of a child with ASD. Moreover, the literature is especially limited regarding adolescence (12 - 16 years), although this period is associated with additional challenges in parenting, given the multiple physical, social and psychological changes that characterize ...
Corrigendum: Vedolizumab in Paediatric Inflammatory Bowel Disease: A Retrospective Multi-Centre Experience From the Paediatric IBD Porto Group of ESPGHAN. KU Leuven
© 2018 European Crohn's and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved. In the original article, author Carsten Posovszky's surname was incorrectly spelt. This has now been corrected.
Nutrition in Pediatric Inflammatory Bowel Disease Vrije Universiteit Brussel
BACKGROUND AND AIMS: A growing body of evidence supports the need for detailed attention to nutrition and diet in children with inflammatory bowel disease (IBD). We aimed to define the steps in instituting dietary or nutritional management in light of the current evidence and to offer a useful and practical guide to physicians and dieticians involved in the care of pediatric IBD patients.
METHODS: A group of 20 experts in pediatric ...